Avalo Therapeutics, Inc. · NASDAQ:AVTX

Balyasny Asset Management L.P. reported a 6.22% stake in Avalo Therapeutics, Inc. (Schedule 13G)

Event Sep 30, 2025 · Filed Nov 14, 2025

Balyasny Asset Management L.P. reported a 6.22% stake in Avalo Therapeutics, Inc., 817,436 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).

Stake
6.22%
Shares
817,436
Intent
Passive
What changed
Crossed above 5%
Filed together
5 holders

The filing in full

HolderStakeShares
Balyasny Asset Management L.P.6.22%817,436
BAM GP LLC6.22%817,436
Balyasny Asset Management Holdings LP6.22%817,436
Dames GP LLC6.22%817,436
Dmitry Balyasny6.22%817,436

Source

View original at SEC

Related